Topic summary
63%12 analyzed articles/videos5,716 analyzed words
BS Summary: These Drug Pricing results contain 44 faulty reasoning types, including Negativity Bias, Appeal to Authority, and Optimism Bias, with Framing Effect as the most egregious example at 18.3% saturation with 3,876 hits. Analysis detected 22,418 faulty-reasoning hits from 21,192 analyzed words across 12 articles, generating a BS Score of 2.4% and a BS Rank of 36% (10,095 of 15,755 topics). This Drug Pricing is better (less manipulative) than 64.10% of the peer group.
Drug Pricing

Ranking context

Position among analyzed topics

36% percentile
025507510035.9% percentile
2.4% BS Score12 analyzed articles21.2K analyzed words

Reasoning profile

Selected profile versus the sitewide rate

TopicSitewideShared scale 0–50%
0.0%10%20%30%40%50%Negativity BiasSitewide 19.2%Topic 8.2%8.2%Appeal to EmotionSitewide 15.9%Topic 5.3%5.3%Framing EffectSitewide 26.9%Topic 18.3%18.3%Availability HeuristicSitewide 9.1%Topic 1.5%1.5%In-Group BiasSitewide 6.9%Topic 1.9%1.9%Confirmation BiasSitewide 7.5%Topic 2.9%2.9%Appeal to AuthoritySitewide 11.1%Topic 6.6%6.6%Halo EffectSitewide 6.7%Topic 2.5%2.5%AnecdotalSitewide 5.2%Topic 1.6%1.6%Out-Group Homogeneity BiasSitewide 3.1%Topic 0.3%0.3%

Sitewide departure map

Above the diagonal means this profile uses the pattern more often

0.0%0.0%10%10%20%20%30%30%40%40%50%50%Framing Effect: Topic 18.3%, sitewide 26.9%Negativity Bias: Topic 8.2%, sitewide 19.2%Appeal to Emotion: Topic 5.3%, sitewide 15.9%Appeal to Authority: Topic 6.6%, sitewide 11.1%Availability Heuristic: Topic 1.5%, sitewide 9.1%Hasty Generalization: Topic 6.0%, sitewide 8.1%Confirmation Bias: Topic 2.9%, sitewide 7.5%In-Group Bias: Topic 1.9%, sitewide 6.9%Halo Effect: Topic 2.5%, sitewide 6.7%Optimism Bias: Topic 6.3%, sitewide 6.0%Biased Writer Voice: Topic 6.1%, sitewide 5.3%Anchoring Bias: Topic 5.8%, sitewide 4.0%Anecdotal: Topic 1.6%, sitewide 5.2%Overconfidence Bias: Topic 4.4%, sitewide 4.6%Pessimism Bias: Topic 4.1%, sitewide 1.9%Self-Serving Bias: Topic 1.9%, sitewide 3.7%Post Hoc (False Cause): Topic 2.4%, sitewide 3.3%Out-Group Homogeneity Bias: Topic 0.3%, sitewide 3.1%Fundamental Attribution Error: Topic 0.3%, sitewide 2.7%Recency Bias: Topic 0.7%, sitewide 2.7%Loss Aversion: Topic 1.0%, sitewide 2.5%Bandwagon: Topic 1.6%, sitewide 2.2%Status Quo Bias: Topic 1.0%, sitewide 2.2%Ad Hominem: Topic 0.2%, sitewide 2.2%Framing EffectSitewide rateTopic rate

Analyzed articles and videos

STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and more60%
STAT43%By Ed Silverman61%7/21/2026, 1:08:39 PM
FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access81%
STAT43%By Ed Silverman61%7/14/2026, 8:55:49 PM
Sales from controversial U.S. drug discount program rose to $100 billion last year30%
STAT43%By Ed Silverman61%7/14/2026, 7:57:23 PM
Medicare proposes cuts to hospital reimbursement for 340B drugs84%
STAT43%By Tara Bannow66%7/2/2026, 7:52:19 PM
Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals57%
STAT43%By Ed Silverman61%7/2/2026, 7:52:14 PM
U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug84%
STAT43%By Ed Silverman61%7/2/2026, 12:54:40 PM
The Shaky Assumptions Behind Trump’s Over $500 Billion in Projected Drug Savings9%
FactCheck.org3%By Kate Yandell4%6/18/2026, 4:26:56 PM
Americans paying less as Trump drug pricing push slashes GLP-1, fertility medicine costs, official says0%
Fox Business91%By Arabella Bennett97%4/7/2026, 6:02:44 PM
White House announces new round of drug-price deals89%
NPR (Shots - Health News)84%By Yuki Noguchi0%12/19/2025, 10:55:14 PM
Trump secures agreements with major drugmakers to lower Medicaid prescription costs for Americans80%
Fox Business91%By Julia Bonavita0% Alexandra Koch0%12/19/2025, 7:25:36 PM